Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

Healthcare Biotechnology

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

Add To Watchlist

NDAQ:IPA - Post Discussion

Immunoprecise Antibodies Ltd > ImmunoPrecise Reports Financial Results and Recent Business

View:

Post by averagepennies on Jul 07, 2023 9:13am

ImmunoPrecise Reports Financial Results and Recent Business

The Company achieved revenue of $20.7 million during the year ended April 30, 2023, a 6.7% increase from the year ended April 30, 2022. YoY growth increases to 9.0% when adjusting for the effects of currency translation.
The Company recorded total revenue of $5.6 million during the three months ended April 30, 2023, the highest quarterly revenue total the Company has recorded.

https://www.businesswire.com/news/home/20230707007529/en/

133